Ledger.Open graph →
SEC Form D · filed October 22, 2018

RedShift BioAnalytics, Inc

Offering
$10.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Other Technology
Location
BURLINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Paul Tardif · Burlington, MADirectorKimberly A. Arntson · Vancouver, British Columbia, CanadaExec · DirectorPaul Tardif · Burlington, MADirectorKathleen A. Pecard · Brookfield, WIDirectorEugene Ma · Burlington, MAExecKeith W. Bank · San Ramon, CADirectorJoshua Pierce · San Francisco, CADirectorFelix D. Navarro-Grau Hurtado · Vancouver, British Columbia, CanadaExecWilliam Cadogan · Burlington, MADirectorDaniel B. Stein · Fayetteville, ARDirectorCarl C. Riedy · Washington, Washington, D.C.Exec · DirectorStephen W. Farr · San Ramon, CADirectorChristopher C. Cox · Lansing, MIExecBryson Holliman · Burlington, MADirectorFrank Smith · Burlington, MADirectorCharles Marshall · Burlington, MAExec · DirectorCatherine A. Cawthon · Dublin, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗